Close Menu

NEW YORK (360Dx) — The broader market pushed down the stock prices of many diagnostic companies in May as the 360Dx Index declined almost 3 percent month over month.

In all, 21 companies in the index saw their share values shrink last month compared to April, while six firms' stock prices grew.

A weak overall market was largely to blame for the month-over-month softness in diagnostic stocks. The Dow Jones Industrial Average was down 7 percent in May compared to April, while the Nasdaq was down 8 percent, and the Nasdaq Biotech Index declined 6 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.